We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$420B
AUM Growth
+$48.9B
Cap. Flow
+$5.44B
Cap. Flow %
1.29%
Top 10 Hldgs %
14.58%
Holding
3,965
New
126
Increased
1,970
Reduced
1,592
Closed
143

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$444M
2
SNPS icon
Synopsys
SNPS
+$348M
3
PDD icon
Pinduoduo
PDD
+$326M
4
NTES icon
NetEase
NTES
+$314M
5
DXCM icon
DexCom
DXCM
+$302M

Sector Composition

Rank Sector Weight
1 Technology 23.37%
2 Financials 12.15%
3 Industrials 11.37%
4 Healthcare 11.18%
5 Consumer Discretionary 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKSY icon
3601
BlackSky Technology
BKSY
$919M
$78.9K ﹤0.01%
7,043
+1,346
+24% +$13.7K
INZY
3602
DELISTED
Inozyme Pharma
INZY
$76K ﹤0.01%
17,843
+4,795
+37% +$17K
SNMP
3603
DELISTED
Evolve Transition Infrastructure LP
SNMP
$75.7K ﹤0.01%
58,252
VUZI icon
3604
Vuzix
VUZI
$194M
$75.3K ﹤0.01%
36,130
+11,830
+49% +$32.2K
ULCC icon
3605
Frontier Group Holdings
ULCC
$1.61B
$74.5K ﹤0.01%
13,645
-2,367
-15% -$10.4K
TDUP icon
3606
ThredUp
TDUP
$757M
$73.3K ﹤0.01%
32,597
+4,517
+16% +$11.7K
AMPY icon
3607
Amplify Energy
AMPY
$155M
$72.6K ﹤0.01%
+12,244
New +$79K
KLTR icon
3608
Kaltura
KLTR
$206M
$71.6K ﹤0.01%
36,727
-5,661
-13% -$9.99K
BCOV
3609
DELISTED
Brightcove, Inc.
BCOV
$71.2K ﹤0.01%
27,486
+4,732
+21% +$12.7K
NRDY icon
3610
Nerdy
NRDY
$107M
$71.1K ﹤0.01%
20,738
-4,036
-16% -$12.4K
LYG icon
3611
Lloyds Banking Group
LYG
$90.7B
$70.7K ﹤0.01%
29,601
-173,710
-85% -$372K
ESPR
3612
DELISTED
Esperion Therapeutics
ESPR
$69.3K ﹤0.01%
23,176
+681
+3% +$883
CLPT icon
3613
ClearPoint Neuro
CLPT
$437M
$69.3K ﹤0.01%
10,199
-1,335
-12% -$7.56K
NAUT icon
3614
Nautilus Biotechnolgy
NAUT
$131M
$67.9K ﹤0.01%
22,712
+5,010
+28% +$14.3K
ERAS icon
3615
Erasca
ERAS
$6.48B
$67.7K ﹤0.01%
31,798
+7,913
+33% +$16.7K
CMPX icon
3616
Compass Therapeutics
CMPX
$349M
$67.4K ﹤0.01%
43,190
-22,906
-35% -$39.6K
CGC
3617
Canopy Growth
CGC
$388M
$65.9K ﹤0.01%
12,898
-379
-3% -$2.26K
REI icon
3618
Ring Energy
REI
$315M
$65.8K ﹤0.01%
45,093
+10,846
+32% +$17.9K
AUTL
3619
Autolus Therapeutics
AUTL
$407M
$64.9K ﹤0.01%
10,078
-236
-2% -$900
JOAN
3620
DELISTED
JOANN, Inc. Common Stock
JOAN
$63.6K ﹤0.01%
142,554
+1,564
+1% +$918
LCTX icon
3621
Lineage Cell Therapeutics
LCTX
$277M
$62K ﹤0.01%
56,879
-9,013
-14% -$9.87K
EXFY icon
3622
Expensify
EXFY
$178M
$60.4K ﹤0.01%
24,437
-4,851
-17% -$12.6K
VTYX
3623
DELISTED
Ventyx Biosciences
VTYX
$59.9K ﹤0.01%
24,258
-2,502
-9% -$23.8K
HUMA icon
3624
Humacyte
HUMA
$181M
$59.9K ﹤0.01%
21,093
-2,551
-11% -$6.55K
PGEN icon
3625
Precigen
PGEN
$2.12B
$59.6K ﹤0.01%
44,483
+12,959
+41% +$15.2K

Similar funds

Invesco's Q4 2023 Portfolio in Review

As of Q4 2023, Invesco held 3,965 positions worth $420B, up 13% from $371B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Invesco's Q4 2023 filing shows 126 new, 1,970 increased, 1,592 reduced and 143 closed positions. Its largest new stake was Veralto: 4,358,553 shares worth $359M. The largest sale was Pioneer Natural Resource Co., an estimated $444M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.

  • Invesco's largest Q4 2023 buy was Veralto: 4,358,553 shares worth $359M.
  • Invesco added most to Texas Instruments in Q4 2023, an estimated $580M increase.
  • Invesco's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $444M.
  • Invesco fully exited Activision Blizzard in Q4 2023, selling an estimated $186M.
  • Invesco's ten largest holdings make up 15% of its $420B portfolio in Q4 2023.
  • Invesco opened 126 new positions and closed 143 in Q4 2023.
  • Invesco's portfolio value rose 13% quarter-over-quarter to $420B.

Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.